Adherence to guidelines for the prevention of HIV-related respiratory diseases

European Respiratory Journal

Volumn 9, Issue 11, 1996, Pages 2318-2322

  Montaner, J S G ^a   Phillips, P ^a   Zala, C ^a   Craib, K J P ^a   O'Shaughnessy, M V ^a   Schechter, M T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acquired Immune Deficiency Syndrome; Human immunodeficiency virus; Pneumocystis carinii; Pneumonia; Prophylaxis; Tuberculosis

Indexed keywords

COTRIMOXAZOLE; DAPSONE; INFLUENZA VACCINE; PENTAMIDINE; PNEUMOCOCCUS VACCINE; TUBERCULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; HEALTH CARE UTILIZATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; TUBERCULIN TEST; VACCINATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL VACCINES; CD4 LYMPHOCYTE COUNT; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; INFLUENZA VACCINES; LUNG DISEASES; MALE; PATIENT COMPLIANCE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PNEUMONIA, PNEUMOCYSTIS; STREPTOCOCCUS PNEUMONIAE; TUBERCULIN TEST; VACCINATION;

EID: 0029860482     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09112318     Document Type: Article

References (27)

1. Montaner JSG, Le TN, Hogg RS, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994; 8: 693-696.
2. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989; 38: 1-9.
3. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunod-eficiency virus. MMWR 1992; 41 (RR-4): 1-11.
4. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the elimination of tuberculosis. MMWR 1989; 38: 236-250.
5. Centers for Disease Control. Purified protein derivative (PPD), tuberculin, anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991; 40 (RR-5): 27-33.
6. Centers for Disease Control. Prevention and control of influenza: recommendations of Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40: 1-15.
7. Centers for Disease Control. Pneumococcal recommendations of the Immunization Practices Advisory Committees: pneumococcal polysaccharide vaccine. MMWR 1989; 38: 64-76.
8. Leoung GS, Feigal DW, Montgomery AB, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. N Engl J Med 1990; 323: 769-775.
9. Montaner JSG, Lawson LM, Gervais A, et al. A place-bo-controlled study of aerosol pentamidine for the secondary prophylaxis of AIDS-related PCP. Ann Intern Med 1991; 114(11): 948-953.
10. Hirschel B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 334: 1079-1083.
11. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-1460.
12. Broome CV, Breiman RS. Pneumococcal vaccine test present and future. N Engl J Med 1991; 325: 1506-1508.
13. Rose BN, Schechter CB, Sacks HS. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993; 94: 160-168.
14. Nelson KE, Clements LM, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccine. Ann Intern Med 1988; 109: 383-388.
15. Wortley P, Farizo K, Chu F. Influenza and pneumococcal vaccination coverage among patients with HIV infection in the United States. IXth International Conference on AIDS, Berlin 1993, Vol. I. Abstract Po-B32-2249: 510.
16. Marion SA, Schechter MT, Weaver MS, et al. Evidence that prior immune dysfunction predisposes to human immunodeficiency virus Infection in homosexual men. J Acquir Immune Defic Syndr 1989; 2: 178-186.
17. Glassroth J, Jordan M, Wallace J, et al. Use of preventive interventions by persons infected with type-1 human immunodeficiency virus (HIV-1). Am J Prev Med 1994; 10: 259-266.
18. Broisman L. A comparison of two systems of delivery of care to HIV-infected patients. IXth International Conference on AIDS, Berlin 1993, Vol. 1. Abstract Po-B32-2254: 511.
19. Belcher DW. Implementing preventive services: success and failure in an out-patient trial. Arch Intern Med 1990; 150: 2533-2541.
20. Centers for Disease Control. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39(RR-8): 1-7.
21. Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993; 328: 1252-1258.
22. American College of Physicians Task Force on Adult Immunization, Infectious Diseases Society of American Guide for Adult Immunizations. Second Edn. Philadelphia; American College of Physicians, 1990.
23. Fedson DS, Harward MP, Reid RA, Kaiser DL. Hospital-based pneumococcal immunization: epidemiologic rationale from the Shenandoah study. JAMA 1990; 264: 1117-1122.
24. Safran S, Rush GD, Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990; 98: 33-37.
25. Girard PMG, Landman R, Gaudebout C, et al. Dapsonepyrimethamine compared with aerosol pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328: 1514-1520.
26. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositives individuals in relation to the number of CD4+ lymphocytes. AIDS 1994, 8: 469-476.
27. Korzeniewska-Kosela M, Fitzgerald M, Vedal S, Allen EA, et al. Spectrum of tuberculosis with HIV infection in British Columbia: report of 40 cases. Can Med Assoc J 1992; 146(11): 1927-1934.